10 important updates in breast cancer treatment, survivorship
Breast Cancer Awareness Month, observed every October, is an international campaign designed to increase awareness of the disease and raise money to fund research for prevention, earlier detection and more effective treatment.
In conjunction with this observance, Healio presents 10 research updates in breast cancer screening, diagnosis, treatment and survivorship.
- Nut consumption appeared associated with improved survival among long-term breast cancer survivors. Read more.
- Establishing biennial mammography screening beginning at age 40 years could reduce breast cancer-associated mortality by 57% among Black women. Read more.
- The addition of pembrolizumab (Keytruda, Merck) to first-line chemotherapy led to statistically significant improvement in PFS and OS among patients with PD-L1-positive metastatic triple-negative breast cancer. Read more.
- Black and Hispanic women had a higher risk than white women for ED visits within 90 days after breast cancer surgery. Read more.
- Use of statin therapy within the first year after breast cancer diagnosis appeared associated with a survival benefit among women with stage I to stage III triple-negative disease. Read more.
- More than 40% of patients with breast cancer reported using cannabis to manage their treatment symptoms, yet most patients did not discuss cannabis use with their physicians. Read more.
- High levels of physical activity appeared strongly associated with the ability to maintain cognitive function among women with breast cancer treated with chemotherapy. Read more.
- Fertility preservation after breast cancer diagnosis led to short delays in time to treatment. However, the delays did not negatively affect survival. Read more.
- Total annual costs associated with metastatic breast cancer in the U.S. could exceed $152 billion in 2030. Researchers attributed the estimated increase to a rise in cases among younger women. Read more.
- Breast cancer screening costs have risen considerably since 2013 due to the primary adoption of digital breast tomosynthesis. Read more.